Press release

LulzBot Announces 3D Bioprinting Collaboration With FluidForm

Sponsored by Businesswire

Aleph Objects, Inc., manufacturer of LulzBot 3D Printers, announced
their collaboration with FluidForm Inc., an innovator in 3D bioprinting.
FluidForm’s FRESH printing technique, developed in Carnegie Mellon
University’s Regenerative Biomaterials and Therapeutics Group, enables
3D printing of bioinks and other soft materials. Together, Aleph Objects
and FluidForm will combine their expertise to offer new bioprinting
solutions, with the initial offering coming this summer.

This press release features multimedia. View the full release here:

Aleph Objects Inc., manufacturer of LulzBot 3D Printers, has announced new bioprinting hardware comi ...

Aleph Objects Inc., manufacturer of LulzBot 3D Printers, has announced new bioprinting hardware coming summer of 2019 with the long term goal of building real functional tissues. (Photo: Business Wire)

3D bioprinting is already being used in labs to create tissue scaffolds
and other complex biological structures. “We’re still at the very
beginning of being able to build real functional tissues with 3D
bioprinting,” said FluidForm CTO Adam Feinberg. “Collaborations like the
one we are building with LulzBot will help make this a reality faster.”

3D biofabrication technology is revolutionizing applications across a
wide spectrum of industries, including pharmaceuticals, regenerative
medicine, drug screening, food and other animal products, cell-based
biosensors, and testing of cosmetics and other health care goods. Within
the next decade, major pharmaceutical companies will be able to replace
some animal testing and non-physiological 2D cell culture systems with
clinically-relevant 3D bioprinted human tissues.

FluidForm’s novel platform of Freeform Reversible Embedding of Suspended
Hydrogels (FRESH) 3D printing enables fabrication of soft, biological
scaffolds for applications in tissue engineering and regenerative

“Combining proven expertise in professional 3D printers and hardware
with 3D biofabrication technology is going to be an absolute
game-changer,” said Aleph Objects CEO and President Grant Flaharty. “The
market for 3D bioprinters and 3D bioprinted tissues is estimated to grow
to $1.9 billion by 2028.”

Subscribe and be the first to learn about LulzBot’s bioprinting
advancements and new products!

About Aleph Objects, Inc.

Aleph Objects, Inc. is the Colorado-based designer and manufacturer of
the award-winning line of LulzBot® 3D Printers. LulzBot is a trusted
brand in Automotive, Consumer Products, Aerospace/Defense, Medical, and
Education industries around the globe. Aleph Object’s core company
values of Free Software, Libre Innovation, and Open Source Hardware
enable users to uniquely modify both software and hardware to bring
their imagination to life. For more information, visit

Media Assets: